West Pharmaceutical Services Inc. (WST): Price and Financial Metrics
GET POWR RATINGS... FREE!
WST POWR Grades
- WST scores best on the Quality dimension, with a Quality rank ahead of 79.27% of US stocks.
- The strongest trend for WST is in Growth, which has been heading down over the past 177 days.
- WST ranks lowest in Momentum; there it ranks in the 1st percentile.
WST Stock Summary
- WST has a market capitalization of $20,868,418,376 -- more than approximately 89.73% of US stocks.
- With a one year PEG ratio of 515.61, WEST PHARMACEUTICAL SERVICES INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 94.78% of US stocks.
- WST's went public 35.1 years ago, making it older than 90.34% of listed US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to WEST PHARMACEUTICAL SERVICES INC, a group of peers worth examining would be ALGN, GGG, ATRI, SSTK, and FTV.
- Visit WST's SEC page to see the company's official filings. To visit the company's web site, go to www.westpharma.com.
WST Valuation Summary
- In comparison to the median Healthcare stock, WST's price/earnings ratio is 38.91% higher, now standing at 30.7.
- Over the past 243 months, WST's price/earnings ratio has gone up 86.9.
Below are key valuation metrics over time for WST.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
WST | 2023-01-30 | 6.7 | 7.8 | 30.7 | 25.0 |
WST | 2023-01-27 | 6.8 | 8.0 | 31.5 | 25.6 |
WST | 2023-01-26 | 6.9 | 8.1 | 31.7 | 25.8 |
WST | 2023-01-25 | 6.6 | 7.8 | 30.6 | 24.8 |
WST | 2023-01-24 | 6.6 | 7.7 | 30.3 | 24.6 |
WST | 2023-01-23 | 6.7 | 7.9 | 31.0 | 25.2 |
WST Growth Metrics
- Its 2 year price growth rate is now at 66.39%.
- The 5 year price growth rate now stands at 102.53%.
- The 2 year net cashflow from operations growth rate now stands at 71.62%.

The table below shows WST's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 2,909 | 654 | 630.6 |
2022-06-30 | 2,928.6 | 675.2 | 685.6 |
2022-03-31 | 2,880.9 | 646.5 | 684.4 |
2021-12-31 | 2,831.6 | 584 | 661.8 |
2021-09-30 | 2,681 | 571.9 | 612.5 |
2021-06-30 | 2,522.5 | 500.4 | 519.2 |
WST's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- WST has a Quality Grade of B, ranking ahead of 77.04% of graded US stocks.
- WST's asset turnover comes in at 0.924 -- ranking 9th of 22 Rubber and Plastic Products stocks.
- TUP, MYE, and ENTG are the stocks whose asset turnover ratios are most correlated with WST.
The table below shows WST's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.924 | 0.405 | 0.359 |
2021-06-30 | 0.913 | 0.394 | 0.328 |
2021-03-31 | 0.885 | 0.375 | 0.281 |
2020-12-31 | 0.857 | 0.358 | 0.238 |
2020-09-30 | 0.852 | 0.348 | 0.220 |
2020-06-30 | 0.850 | 0.341 | 0.206 |
WST Price Target
For more insight on analysts targets of WST, see our WST price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $436.00 | Average Broker Recommendation | 1.5 (Moderate Buy) |
WST Stock Price Chart Interactive Chart >
WST Price/Volume Stats
Current price | $272.88 | 52-week high | $424.00 |
Prev. close | $281.88 | 52-week low | $206.19 |
Day low | $269.55 | Volume | 466,300 |
Day high | $276.49 | Avg. volume | 586,022 |
50-day MA | $244.33 | Dividend yield | 0.28% |
200-day MA | $278.51 | Market Cap | 20.20B |
West Pharmaceutical Services Inc. (WST) Company Bio
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. Founded in 1923 by Herman O. West and J.R. Wike of Philadelphia, the company is headquartered in Exton, Pennsylvania. In its early years of development, West produced rubber components for packaging injectable drugs, providing a sterile environment for the producers of penicillin and insulin. (Source:Wikipedia)
Latest WST News From Around the Web
Below are the latest news stories about WEST PHARMACEUTICAL SERVICES INC that investors may wish to consider to help them evaluate WST as an investment opportunity.
West to Host Fourth-Quarter and Full-Year 2022 Conference Call and Announces Participation in Upcoming Investor ConferencesWest Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2022 financial results before the market opens on Thursday, February 16, 2023, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. |
McKesson (MCK) Tops Q3 Earnings and Revenue EstimatesMcKesson (MCK) delivered earnings and revenue surprises of 8.83% and 0.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? |
West Announces Three New Product Innovations at Pharmapack EuropeWest Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced participation at Pharmapack Europe 2023 in Paris, France to showcase its leadership and expertise on industry challenges and trends in packaging and containment. The company expands its innovations for global customers and their patients with the introduction of three new products: West Ready Pack™ with Corning Valor® RTU Vials utilizing Stevanato Group's EZ |
Dividend Kings and Aristocrats List: 50 Biggest StocksIn this article, we will discuss 50 biggest dividend kings and dividend aristocrats. You can skip our detailed analysis of dividend stocks and their returns in the past, and go directly to read Dividend Kings and Aristocrats List: 10 Biggest Stocks. Dividend Aristocrats and Dividend Kings are the companies that have raised their dividend payouts for […] |
Monday Is Your Last Chance To Buy West Pharmaceutical Servs Before The Dividend PayoutMonday marks the last chance for investors to receive the next dividend payout from West Pharmaceutical Servs (NYSE: WST ). What''s Happening The company announced on Tuesday that it would pay shareholders a quarterly dividend of 19 cents per share. On Tuesday, West Pharmaceutical Servs will go ex-dividend, meaning the stock will trade lower to reflect that payout. … Full story available on Benzinga.com |
WST Price Returns
1-mo | 17.45% |
3-mo | 21.61% |
6-mo | -19.34% |
1-year | -31.73% |
3-year | 72.77% |
5-year | 194.81% |
YTD | 16.03% |
2022 | -49.70% |
2021 | 65.88% |
2020 | 89.05% |
2019 | 54.13% |
2018 | -0.08% |
WST Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching WST
Want to do more research on West Pharmaceutical Services Inc's stock and its price? Try the links below:West Pharmaceutical Services Inc (WST) Stock Price | Nasdaq
West Pharmaceutical Services Inc (WST) Stock Quote, History and News - Yahoo Finance
West Pharmaceutical Services Inc (WST) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...